These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29102648)

  • 1. Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
    Shi W; Scannell Bryan M; Gilbert MR; Mehta MP; Blumenthal DT; Brown PD; Valeinis E; Hopkins K; Souhami L; Andrews DW; Tzuk-Shina T; Howard SP; Youssef EF; Lessard N; Dignam JJ; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):38-44. PubMed ID: 29102648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma: patterns of recurrence and efficacy of salvage treatments.
    Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR
    Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
    JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.
    Park CK; Lee SH; Kim TM; Choi SH; Park SH; Heo DS; Kim IH; Jung HW
    J Neurooncol; 2013 Apr; 112(2):277-83. PubMed ID: 23377829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
    Kesari S; Ram Z;
    CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J;
    Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
    Niyazi M; Schwarz SB; Suchorska B; Belka C
    Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
    Ogura K; Mizowaki T; Arakawa Y; Ogura M; Sakanaka K; Miyamoto S; Hiraoka M
    Radiat Oncol; 2013 Apr; 8():97. PubMed ID: 24499582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
    Kim MM; Speers C; Li P; Schipper M; Junck L; Leung D; Orringer D; Heth J; Umemura Y; Spratt DE; Wahl DR; Cao Y; Lawrence TS; Tsien CI
    J Neurooncol; 2019 Jun; 143(2):313-319. PubMed ID: 30977058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.
    Woo P; Ho J; Lam S; Ma E; Chan D; Wong WK; Mak C; Lee M; Wong ST; Chan KY; Poon WS
    World Neurosurg; 2018 Jul; 115():e375-e385. PubMed ID: 29678708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
    Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
    Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
    Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
    Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors.
    Yaneva MP; Semerdjieva ML; Radev LR; Vlaikova MI
    Folia Med (Plovdiv); 2010; 52(1):26-33. PubMed ID: 20380284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab.
    Magnuson W; Ian Robins H; Mohindra P; Howard S
    J Neurooncol; 2014 Mar; 117(1):133-9. PubMed ID: 24469853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.
    Minniti G; Armosini V; Salvati M; Lanzetta G; Caporello P; Mei M; Osti MF; Maurizi RE
    J Neurooncol; 2011 Jul; 103(3):683-91. PubMed ID: 21052773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.
    Tsien CI; Brown D; Normolle D; Schipper M; Piert M; Junck L; Heth J; Gomez-Hassan D; Ten Haken RK; Chenevert T; Cao Y; Lawrence T
    Clin Cancer Res; 2012 Jan; 18(1):273-9. PubMed ID: 22065084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.